REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 17th, 2022 • Aprea Therapeutics, Inc. • Pharmaceutical preparations • New York
This Registration Rights Agreement (this “Agreement”) is dated as of May 16, 2022, by and among Aprea Therapeutics, Inc., a Delaware corporation (the “Company”), and the several purchasers signatory hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
AGREEMENT AND PLAN OF MERGER among: APREA THERAPEUTICS, INC., a Delaware corporation; ATR MERGER SUB I INC., a Delaware corporation; ATR MERGER SUB II LLC, a Delaware limited liability company; and ATRIN PHARMACEUTICALS INC., a Delaware corporation...Agreement and Plan of Merger • May 17th, 2022 • Aprea Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS AGREEMENT AND PLAN OF MERGER is made and entered into as of May 16, 2022, by and among Aprea Therapeutics, Inc., a Delaware corporation (“Parent”), ATR Merger Sub I Inc., a Delaware corporation and wholly owned Subsidiary of Parent (“First Merger Sub”), ATR Merger Sub II LLC, a Delaware limited liability company and wholly owned Subsidiary of Parent (“Second Merger Sub” and together with First Merger Sub, “Merger Subs”), and Atrin Pharmaceuticals Inc., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Exhibit A.
